62 related articles for article (PubMed ID: 1716086)
1. Antigenic expression changes occurring in adriamycin resistant MCF-7 mammary carcinoma cells.
Nuti M; Zupi G; D'Agnano I; Turchi V; Candiloro A; Frati L
Anticancer Res; 1991; 11(3):1225-30. PubMed ID: 1716086
[TBL] [Abstract][Full Text] [Related]
2. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
4. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
5. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
[TBL] [Abstract][Full Text] [Related]
7. Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line.
Dickstein B; Valverius EM; Wosikowski K; Saceda M; Pearson JW; Martin MB; Bates SE
J Cell Physiol; 1993 Oct; 157(1):110-8. PubMed ID: 8408230
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
9. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
Mimnaugh EG; Dusre L; Atwell J; Myers CE
Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines.
Monti E; Sinha BK
Anticancer Res; 1994; 14(3A):1221-6. PubMed ID: 8074476
[TBL] [Abstract][Full Text] [Related]
11. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
Chen J; Yuan YW; Zhang JR; Zhou DY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):124-6. PubMed ID: 12390804
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells.
Greiner JW
Anticancer Res; 1986; 6(4):653-8. PubMed ID: 3752945
[TBL] [Abstract][Full Text] [Related]
13. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
14. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells.
Scaddan PB; Dufresne MJ
Invasion Metastasis; 1993; 13(6):301-13. PubMed ID: 7860223
[TBL] [Abstract][Full Text] [Related]
16. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.
Fairchild CR; Ivy SP; Kao-Shan CS; Whang-Peng J; Rosen N; Israel MA; Melera PW; Cowan KH; Goldsmith ME
Cancer Res; 1987 Oct; 47(19):5141-8. PubMed ID: 2441861
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of integrins in adriamycin-resistant human breast cancer cells.
Narita T; Kimura N; Sato M; Matsuura N; Kannagi R
Anticancer Res; 1998; 18(1A):257-62. PubMed ID: 9568087
[TBL] [Abstract][Full Text] [Related]
18. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
19. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.
Shimada S; Ogawa M; Schlom J; Greiner JW
Cancer Res; 1991 Oct; 51(20):5694-703. PubMed ID: 1913687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
